Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 2 |
2022 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers.
Cancer Immunol Immunother. 2021 Sep;70(9):2669-2679. doi: 10.1007/s00262-021-02878-8. Epub 2021 Feb 23.
Cancer Immunol Immunother. 2021.
PMID: 33624146
Free PMC article.
[Can tumor vaccines really cure liver cancer?].
Chen DB, Chen P, Chen HS.
Chen DB, et al.
Zhonghua Gan Zang Bing Za Zhi. 2022 Sep 20;30(9):918-922. doi: 10.3760/cma.j.cn501113-20220706-00370.
Zhonghua Gan Zang Bing Za Zhi. 2022.
PMID: 36299183
Chinese.
Item in Clipboard
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.
Wang Y, Chen H, Jiao X, Wu L, Yang Y, Zhang J, Wu L, Liu C, Zhuo N, Li S, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Li J, Li Y, Lu Z, Zhang H, Shen L.
Wang Y, et al.
Cancer Immunol Immunother. 2022 Jan;71(1):111-120. doi: 10.1007/s00262-021-02966-9. Epub 2021 May 24.
Cancer Immunol Immunother. 2022.
PMID: 34028566
Free PMC article.
Item in Clipboard
PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer.
Chen Y, Liu Q, Chen Z, Wang Y, Yang W, Hu Y, Han W, Zeng H, Ma H, Dai J, Zhang H.
Chen Y, et al.
J Exp Clin Cancer Res. 2019 May 14;38(1):193. doi: 10.1186/s13046-019-1192-1.
J Exp Clin Cancer Res. 2019.
PMID: 31088500
Free PMC article.
Item in Clipboard
Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer.
Wu X, Zhang C, Zhang H.
Wu X, et al.
Curr Oncol. 2022 Jan 10;29(1):283-293. doi: 10.3390/curroncol29010026.
Curr Oncol. 2022.
PMID: 35049700
Free PMC article.
Item in Clipboard
Cite
Cite